Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention

被引:14
|
作者
Chang, Joyce C. [1 ,2 ,3 ]
Xiao, Rui [3 ,4 ]
Burnham, Jon M. [1 ,3 ,5 ]
Weiss, Pamela F. [1 ,2 ,3 ,6 ]
机构
[1] Childrens Hosp Philadelphia, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Res Inst, 2716 South St,11th Floor, Philadelphia, PA 19146 USA
[3] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Off Clin Qual Improvement, Philadelphia, PA 19104 USA
[6] Univ Penn, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19146 USA
关键词
Juvenile arthritis; Healthcare disparities; Patient outcome assessment; Patient reported outcome measures; Pediatrics; MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; ETHNIC DISPARITIES; TREATMENT PREFERENCES; MULTICENTER; OUTCOMES; CHILDREN; RACE;
D O I
10.1186/s12969-020-00485-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background We sought to evaluate racial disparities in disease outcomes among children with polyarticular juvenile idiopathic arthritis (JIA) during a treat-to-target (TTT) intervention with clinical decision support (CDS). Methods This was a retrospective analysis of a TTT-CDS strategy integrated into clinical practice for children with polyarticular JIA at a single center from 2016 to 2019. The primary outcome was the clinical Juvenile Arthritis Disease Activity Score (cJADAS-10). We used multivariable linear regression to assess racial differences in disease outcomes at the index visit (first visit after implementation). The effect of race on disease outcomes over time was estimated using linear mixed-effects models, stratified by incident or prevalent disease. Results We included 159 children with polyarticular JIA, of which 74, 13 and 13% were white, black, and Asian/other, respectively. cJADAS-10 improved significantly over time for all race categories, while the rates of improvement did not differ by race in incident (p = 0.53) or prevalent cases (p = 0.58). cJADAS-10 over time remained higher among black children compared to white children (beta 2.5, p < 0.01 and beta 1.2, p = 0.08 for incident and prevalent cases, respectively). Provider attestation to CDS use at >= 50% of encounters was associated with a 3.9 greater reduction in cJADAS-10 among black children compared to white children (p = 0.02). Conclusion Despite similar rates of improvement over time by race, disparities in JIA outcomes persisted throughout implementation of a TTT-CDS approach. More consistent CDS use may have a greater benefit among black children and needs to be explored further.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis A prospective study on efficacy and safety in a Saudi population
    Mohammed, R. H. A.
    Kewan, H. H.
    Bukhari, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (08): : 746 - 753
  • [42] Treg fitness signatures as a biomarker for disease activity in Juvenile Idiopathic Arthritis
    Attrill, Meryl H.
    Shinko, Diana
    Viveiros, Telma Martins
    Milighetti, Martina
    de Gruijter, Nina M.
    Jebson, Bethany
    Kartawinata, Melissa
    Rosser, Elizabeth C.
    Wedderburn, Lucy R.
    Pesenacker, Anne M.
    JOURNAL OF AUTOIMMUNITY, 2025, 152
  • [43] Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis
    Trincianti, Chiara
    Van Dijkhuizen, Evert Hendrik Pieter
    Alongi, Alessandra
    Mazzoni, Marta
    Swart, Joost F.
    Nikishina, Irina
    Lahdenne, Pekka
    Rutkowska-Sak, Lidia
    Avcin, Tadej
    Quartier, Pierre
    Panaviene, Violeta
    Uziel, Yosef
    Pruunsild, Chris
    Vargova, Veronika
    Vilaiyuk, Soamarat
    Dolezalova, Pavla
    Ringold, Sarah
    Garrone, Marco
    Ruperto, Nicolino
    Ravelli, Angelo
    Consolaro, Alessandro
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (11) : 1966 - 1975
  • [44] Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis
    Bergman, Martin Jan
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (03) : 260 - 267
  • [45] Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis
    Gueddari, S.
    Amine, B.
    Rostom, S.
    Badri, D.
    Mawani, N.
    Ezzahri, M.
    Moussa, F.
    Shyen, S.
    Abouqal, R.
    Chkirat, B.
    Hajjaj-Hassouni, N.
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1289 - 1294
  • [46] Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis
    Martin Jan Bergman
    Current Treatment Options in Rheumatology, 2020, 6 : 260 - 267
  • [47] Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies
    Vidqvist, Krista-Liisa
    Malin, Merja
    Varjolahti-Lehtinen, Tuire
    Korpela, Markku M.
    RHEUMATOLOGY, 2013, 52 (11) : 1999 - 2003
  • [48] Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis
    Calasan, Maja Bulatovic
    de Vries, Lara D.
    Vastert, Sebastiaan J.
    Heijstek, Marloes W.
    Wulffraat, Nico M.
    RHEUMATOLOGY, 2014, 53 (02) : 307 - 312
  • [49] A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study
    Heale, Liane D.
    Dover, Saunya
    Goh, Y. Ingrid
    Maksymiuk, Victoria A.
    Wells, Greg D.
    Feldman, Brian M.
    PEDIATRIC RHEUMATOLOGY, 2018, 16
  • [50] PROMIS Computer Adaptive Tests and Their Correlation With Disease Activity in Juvenile Idiopathic Arthritis
    Trachtman, Rebecca
    Wang, Cindy M.
    Murray, Elizabeth
    Szymonifka, Jackie
    Pan, Nancy
    Adams, Alexa B.
    Taber, Sarah F.
    Onel, Karen B.
    Mandl, Lisa A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (04) : 131 - 135